- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/05 - Dipeptides
Patent holdings for IPC class A61K 38/05
Total number of patents in this class: 1792
10-year publication summary
|
172
|
151
|
156
|
126
|
129
|
110
|
111
|
108
|
77
|
10
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| SeaGen Inc | 565 |
25 |
| Novmetapharma Co., Ltd. | 76 |
20 |
| Genentech, Inc. | 4038 |
14 |
| The Johns Hopkins University | 5774 |
14 |
| Albireo AB | 175 |
14 |
| Dana-Farber Cancer Institute, Inc. | 2635 |
14 |
| Ramot at Tel-Aviv University Ltd. | 1510 |
14 |
| Biohaven Therapeutics Ltd. | 115 |
14 |
| The Regents of the University of California | 20378 |
13 |
| Oncopeptides Innovation AB | 28 |
13 |
| Abbvie Inc. | 1827 |
12 |
| Azurity Pharmaceuticals, Inc. | 236 |
11 |
| Duke University | 3158 |
10 |
| L.e.a.f. Holdings Group LLC | 118 |
10 |
| Axcella (assignment for The Benefit of Creditors), LLC | 39 |
10 |
| Pfizer Inc. | 3374 |
9 |
| Centre National de La Recherche Scientifique | 10805 |
9 |
| The General Hospital Corporation | 4798 |
9 |
| President and Fellows of Harvard College | 6053 |
9 |
| Ajinomoto Co., Inc. | 2300 |
9 |
| Other owners | 1539 |